Table of Contents Table of Contents
Previous Page  8 / 260 Next Page
Information
Show Menu
Previous Page 8 / 260 Next Page
Page Background

I S S U E 1 3

H O R I Z O N 2 0 2 0 P R O J E C T S : P O R T A L

www.horizon2020projects.com

8

SOCIETAL CHALLENGES: HEALTH (continued)

152

PROFILE:

The Sparr Group of the Division of Physical Chemistry at Lund University, Sweden, explains the physical chemistry of skin

152

PROFILE:

The CABMM explains why ethical consideration for animal experiments should be the everyday business of researchers

154

FINLAND FIRST

156

Portal

outlines the life sciences and research funding landscape in Finland

PROFILE:

The Minerva Foundation Institute is a Finland-based organisation studying at the interface between clinical and basic science

158

THE COMPLEX G-QUADRUPLEX

160

The University of Leicester’s Dr Cyril Dominguez on RNA splicing and G-quadruplexes, and their implications for cancer

PROFILE:

LMU Munich’s Department of Chemistry shows how fluorescence is making new ground in biology

164

NEUROSCIENCE

165

A TRANSLATIONAL APPROACH TO CMT

Professor Martin Flück of the Laboratory for Muscle Plasticity discusses how peripheral mechanisms promote motor neuron

function, and advocates a translational approach in Charcot-Marie-Tooth disease (CMT), the most common inherited

neurologic disorder

MOLECULAR MECHANICS

168

Professor Dr Ulrich Eisel introduces the work of the Molecular Neurobiology group at the Groningen Institute for Evolutionary Life Sciences

PROFILE:

Collaboration between the universities of Groningen and Stuttgart has revealed new treatments for neurological disorders

169

HEPATOLOGY

170

LEADING ON THE LIVER

Dr Peter Ferenci met with

Portal

in the Austrian capital Vienna to discuss issues relating to liver disease

EUROPE’S ALCOHOL PROBLEM

174

UEG liver expert Professor Helena Cortez-Pinto caught up with

Portal

in Vienna to discuss alcohol-related liver disease

ONCOLOGY

176

THE CUTTING EDGE OF CANCER CARE

Dr Sarah Bohndiek is working to enhance cancer patient survival via the design of innovative new imaging techniques

PROFILE:

With the aim of saving lives, Life Length, based in Madrid, Spain, discusses the common denominator between ageing and cancer

180

PROFILE:

Researchers from the University of Mons, Belgium, discuss ‘metabonomics’ – the complex signatures of the metabolome

182

THE SILENT CANCER

184

UEG pancreatic cancer specialist Professor Matthias Löhr explores the rise of pancreatic cancer

PROFILE:

Oncologists from Copenhagen University Hospital, Denmark, are focusing on clinical trials in cancer research

186

PROFILE:

King’s Health Partners reveals how prostate cancer can be linked with co-morbidities, a risk of aggressive disease and death

188

TACKLING CHOLANGIOCARCINOMA

190

AMMF CEO Helen Morement discusses some of the known and suspected causes of cholangiocarcinoma

PROFILE:

Scientists at Aintree University Hospital, UK, offer a succinct account of prognosis precision in cholangiocarcinoma

193

BREAST CANCER EXPOSED

194

Breast Cancer UK makes the case for a shift in focus from breast cancer awareness to preventative action on harmful chemical pollutants

PROFILE:

The University of Oulu discusses hypoxia-response pathways and epidermal growth factor receptor signalling crosstalk in breast cancer

197

PROFILE:

Professor Dr Dirk Hempel of Onkologisches Zentrum describes the Oncoguide system for diagnosis and treatment

198

PROGRESS ON THE HUMAN PROTEOME

200

Chair Gilbert S Omenn discusses recent advances from the Human Proteome Organization’s Human Proteome Project

PROFILE:

Researchers at VU University Medical Center, Amsterdam, discuss oncoproteomics in translational research and precision medicine

202

SPECIAL FEATURE: INFECTIOUS DISEASES

205

PREPARING PUBLIC HEALTH

The European Centre for Disease Prevention and Control’s (ECDC) Dr Massimo Ciotti met with

Portal

in Vienna on the sidelines of

the 9th European Public Health Conference ‘All for Health, Health for All’ to discuss core competences for strengthened public

health system preparedness, as well as some of the challenges involved in assessing capability and capacity

AN ONGOING THREAT

208

Professor Dr Martin Schwemmle outlines the ongoing threat of influenza A viruses to the human population

PROFILE:

The Schwemmle Group of the University of Freiburg, Germany, poses a new player in the flu field: bat flu

209

PROFILE:

Dr Brian Kristensen of Denmark’s National Center of Infection Control explains how infection surveillance benefits Danish healthcare

210

SMALL STEPS FOR BIG CHANGE

212

Chair of the Global Hygiene Council Professor John Oxford discusses a new report into preventable infectious diseases in children worldwide

PROFILE:

MeMed’s award-winning technology could help reduce antibiotic misuse

214